Cargando…

Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer

BACKGROUND: Cancer‐related cachexia is a major cause of treatment resistance and poor prognosis, which is characterized by anorexia and skeletal muscle depletion. To date, there have been no reports on the relationship between IL‐35 and cancer‐related cachexia in patients with stage IV non‐small cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zengxun, Zhu, Lei, Zheng, Han, Jiang, Wenna, Wang, Yifei, Jiang, Zhansheng, Xu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888146/ https://www.ncbi.nlm.nih.gov/pubmed/35142058 http://dx.doi.org/10.1111/1759-7714.14307

Ejemplares similares

Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non–Small Cell Lung Cancer
por: Demiray, Gökcen, et al.
Publicado: (2017)

Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD
por: Jiang, Shenghua, et al.
Publicado: (2018)

Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer
por: Jiang, Yi-ming, et al.
Publicado: (2019)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)

Cancer Cachexia: Definition, Staging, and Emerging Treatments
por: Ni, Jun, et al.
Publicado: (2020)

Metabolic Biomarkers for the Early Detection of Cancer Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2021)

Biomarkers for Cancer Cachexia: A Mini Review
por: Cao, Zhipeng, et al.
Publicado: (2021)

The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
por: Hao, Yuqiu, et al.
Publicado: (2022)

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
por: Li, Bob T., et al.
Publicado: (2016)

Biomarkers for cancer cachexia: where do we stand?
por: Palus, Sandra, et al.
Publicado: (2020)

Cancer cachexia.
por: Tisdale, M. J.
Publicado: (1991)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

Cancer cachexia
por: Dhanapal, Raghu, et al.
Publicado: (2011)

The Cachexia of Cancer
por: Williams, W. Roger
Publicado: (1897)

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Murata, Daiki, et al.
Publicado: (2023)

Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
Publicado: (2016)

Evaluation of IL-17 and IL-35 Serum Levels in Patients with Preeclampsia
por: Batebi, Atefeh, et al.
Publicado: (2019)

Muscle function impairment in cancer patients in pre-cachexia stage
por: Dalise, Stefania, et al.
Publicado: (2020)

Identification of key candidate tumor biomarkers in non-small-cell lung cancer by in silico analysis
por: Chen, Weiping, et al.
Publicado: (2020)

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
por: Zhang, Xintong, et al.
Publicado: (2022)

Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia
por: Ebadi, Maryam, et al.
Publicado: (2015)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
por: Donzelli, Sara, et al.
Publicado: (2020)

The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia
por: Laird, Barry J., et al.
Publicado: (2021)

Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia
por: Yang, Quan‐Jun, et al.
Publicado: (2017)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
por: Narasimhan, Ashok, et al.
Publicado: (2020)

The Adipokines in Cancer Cachexia
por: Mannelli, Michele, et al.
Publicado: (2020)

The Microbiota and Cancer Cachexia
por: Herremans, Kelly M., et al.
Publicado: (2019)

Extremely elevated serum procalcitonin concentration in a patient with stage IV non-small cell lung cancer
por: Stando, Rafał, et al.
Publicado: (2023)

IL-18 and IL-35 in the serum of patients with sepsis thrombocytopenia and the clinical significance
por: Zhu, Meirong, et al.
Publicado: (2020)

Decreased serum levels of IL-27and IL-35 in patients with Graves disease
por: Saeed, Malek-Hosseini, et al.
Publicado: (2020)

Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery
por: Pisano, Calogera, et al.
Publicado: (2021)

IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
por: Kourko, Olena, et al.
Publicado: (2019)

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
por: Go, Se‐Il, et al.
Publicado: (2021)

Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Stage III/IV Non-Small Cell Lung Cancer: A Meta-analysis and Systematic Review of 35 Randomized Controlled Trials
por: Li, Hongxiao, et al.
Publicado: (2019)

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
por: Su, Feng, et al.
Publicado: (2007)

Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia
por: Penafuerte, Claudia A, et al.
Publicado: (2016)

Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy
por: Cao, Zhipeng, et al.
Publicado: (2022)

Serum IL-35 Levels Are Associated With Activity and Progression of Sarcoidosis
por: Mengmeng, Zhao, et al.
Publicado: (2020)

Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia
por: Underwood, Patrick W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eu0go989ima9h299ngetsibi1h